ConductScience.org, home

Comparison · NCT06143670-sae

Test Product vs Reference Product (Negative Control): serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Test Product vs Reference Product (Negative Control): serious adverse events. Trial comparisons, record NCT06143670-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT06143670-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 1000.0481wilson
Risk in group 2000.0481wilson
Risk difference, group 1 minus group 20-0.04810.0481newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to harmfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Test Product
Participants were instructed to apply a ribbon of test toothpaste (Parodontax Complete Protection) containing 0.454% w/w SnF2 across the full brush head of toothbrush provided and brush their teeth for at least one (timed) minute twice daily (morning and evening) for 12 weeks.
076EG000
Group 2Reference Product (Negative Control)
Participants were instructed to apply a ribbon of reference toothpaste (Crest Cavity Protection) containing 0.243% w/w sodium fluoride across the full brush head of toothbrush provided and brush their teeth for at least one (timed) minute twice daily (morning and evening) for 12 weeks.
076EG001

Harm

What it counts
Total, serious adverse events
Time frame
From signing of informed consent form until 5 days after last administration of study product or last study procedure (up to approximately 111 days).

Source ClinicalTrials.gov

Trial

Title
A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks
NCT number
NCT06143670
Phases
NA
Conditions
Gingivitis
Interventions
Stannous fluoride toothpaste, Sodium fluoride toothpaste
Lead sponsor
HALEON
Results first posted
2025-03-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT06143670-sae